5. Drug development projects and resource investment under...

5. Drug development projects and resource investment under review The directors have resolved to review the company’s drug development projects and the investment in the USA coal venture and have suspended all associated expenditures. As foreshadowed to shareholders at last year’s AGM, ATC’s Early Access Programme has not attracted any orders despite being available since January 2015 and extensive work by our partner LINK with HIV activist groups internationally. Regarding the coal investment, the directors have noted that oil prices continue to fall to levels completely unforeseen even a few months ago. The oil price flows through to natural gas prices in the USA that are now at record lows and which compete directly with large industrial consumers. In such unprecedented circumstances, it has been extremely difficult to attract a sufficient volume of orders to make the North Pratt coal mine viable. Faced with such circumstances the directors have unanimously decided to concentrate the company’s strategy on TALI’s breakthrough technology in diagnosing intellectual disabilities.